Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 9:31 pm Purchase | 2026-06-30 | 13G | PLIANT THERAPEUTICS INC PLRX | ADAR1 Capital Management LLC | 5,509,724 8.900% | 5,509,724 (New Position) | Filing History |
| 2026-08-14 4:05 pm Sale | 2026-06-30 | 13G | PLIANT THERAPEUTICS INC PLRX | CITADEL ADVISORS LLC | 2,143,426 3.500% | -898,707 (-29.54%) | Filing History |
| 2026-02-17 4:29 pm Sale | 2025-12-31 | 13G | PLIANT THERAPEUTICS INC PLRX | Point72 Asset Management, L.P. | 46,537 0.100% | -4,038,480 (-98.86%) | Filing History |
| 2026-02-17 3:21 pm Sale | 2025-12-31 | 13G | PLIANT THERAPEUTICS INC PLRX | Woodline Partners LP | 2,026,191 3.300% | -2,478,626 (-55.02%) | Filing History |
| 2026-02-09 6:13 pm Purchase | 2026-02-02 | 13G | PLIANT THERAPEUTICS INC PLRX | CITADEL ADVISORS LLC | 3,042,133 5.000% | 4,438 (+0.15%) | Filing History |
| 2026-01-30 7:11 pm Purchase | 2026-01-23 | 13G | PLIANT THERAPEUTICS INC PLRX | CITADEL ADVISORS LLC | 3,037,695 4.900% | 45,780 (+1.53%) | Filing History |
| 2026-01-22 7:02 pm Purchase | 2026-01-14 | 13G | PLIANT THERAPEUTICS INC PLRX | CITADEL ADVISORS LLC | 2,991,915 4.900% | 2,991,915 (New Position) | Filing History |
| 2026-01-08 4:03 pm Sale | 2025-12-31 | 13G | PLIANT THERAPEUTICS INC PLRX | Morgan Stanley MS | 545,228 0.900% | -3,192,107 (-85.41%) | Filing History |
| 2025-11-14 4:17 pm Purchase | 2025-09-30 | 13G | PLIANT THERAPEUTICS INC PLRX | Woodline Partners LP | 4,504,817 7.300% | 4,504,817 (New Position) | Filing History |
| 2025-11-14 08:22 am Sale | 2025-09-30 | 13G | PLIANT THERAPEUTICS INC PLRX | Deep Track Capital, LP | 0 0.000% | -3,947,807 (Position Closed) | Filing History |
| 2025-09-04 5:13 pm Purchase | 2025-08-27 | 13G | PLIANT THERAPEUTICS INC PLRX | Point72 Asset Management, L.P. | 4,085,017 6.700% | 4,085,017 (New Position) | Filing History |
| 2025-08-14 08:49 am Sale | 2025-06-30 | 13G | PLIANT THERAPEUTICS INC PLRX | Deep Track Capital, LP | 3,947,807 6.430% | -1,802,193 (-31.34%) | Filing History |
| 2025-08-06 2:12 pm Purchase | 2025-06-30 | 13G | PLIANT THERAPEUTICS INC PLRX | Morgan Stanley MS | 3,737,335 6.100% | 3,737,335 (New Position) | Filing History |
| 2025-07-29 2:22 pm Sale | 2025-06-30 | 13G | PLIANT THERAPEUTICS INC PLRX | The Vanguard Group | 3,002,348 4.890% | -63,521 (-2.07%) | Filing History |
| 2025-07-17 8:12 pm Sale | 2025-06-30 | 13G | PLIANT THERAPEUTICS INC PLRX | BlackRock, Inc. BLK | 2,104,574 3.400% | -2,696,943 (-56.17%) | Filing History |
| 2025-05-15 4:39 pm Sale | 2025-03-31 | 13G | PLIANT THERAPEUTICS INC PLRX | Paradigm BioCapital Advisors LP | 0 0.000% | -3,059,411 (Position Closed) | Filing History |
| 2025-05-14 10:45 am Sale | 2025-03-31 | 13G | PLIANT THERAPEUTICS INC PLRX | T. Rowe Price Associates, Inc. | 87,674 0.100% | -4,747,139 (-98.19%) | Filing History |
| 2025-03-10 5:24 pm Purchase | 2025-03-03 | 13D | PLIANT THERAPEUTICS INC PLRX | TANG CAPITAL MANAGEMENT LLC | 5,859,044 9.600% | 5,859,044 (New Position) | Filing History |
| 2025-03-07 10:01 am Sale | 2025-02-28 | 13G | PLIANT THERAPEUTICS INC PLRX | FMR LLC | 131,993 0.200% | -3,831,424 (-96.67%) | Filing History |
| 2025-02-14 8:01 pm Sale | 2024-12-31 | 13G | PLIANT THERAPEUTICS INC PLRX | Redmile Group, LLC | 2,895,478 4.800% | -302,013 (-9.45%) | Filing History |